Genetic basis of virus induced Biliary Atresia

病毒引起的胆道闭锁的遗传基础

基本信息

  • 批准号:
    10328541
  • 负责人:
  • 金额:
    $ 44.58万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-04-01 至 2023-12-31
  • 项目状态:
    已结题

项目摘要

Project Summary/Abstract Biliary atresia is the most common cause of pediatric end stage liver disease and the number one indication for pediatric liver transplantation. Because pathogenic viruses have been found in the liver of afflicted children, a proposed etiology for biliary atresia is a perinatal viral infection triggering immune mediated destruction of the biliary epithelium. The murine model of biliary atresia supports a viral pathogenesis as newborn mice infected with rhesus rotavirus (RRV) develop inflammation within the portal tract and extrahepatic bile duct obstruction. RRV targets the cholangiocyte for infection and in addition to direct cholangiocyte injury also induces Natural Killer cell mediated injury to the biliary epithelium. We have previously shown that the amino acid, arginine (R) within the sequence “SRL” (amino acids 445-447) on the RRV VP4 protein is required for viral binding and entry into biliary epithelial cells. We developed a reverse genetics system to create a mutant of RRV (RRVVP4-R446G), which had a single amino acid change in VP4 protein compared to wild type RRV. In vitro, the mutant virus had reduced binding and infectivity in cholangiocytes. In vivo, it produced less symptoms and mortality in neonatal mice, resulting in an attenuated form of biliary atresia. We will use this mutant strain along with additional VP4 mutants to determine how RRV binds to, enters, traffics through the cell, and ultimately activates the cholangiocyte's innate immune response. We will also ascertain these VP4 mutants' ability to infect and activate plasmacytoid dendritic cells leading to Natural Killer cell activation. These complimentary approaches will generate new insight in viral induced biliary atresia.
项目总结/摘要 胆道闭锁是小儿终末期肝病最常见的原因, 小儿肝移植的一个适应症。因为致病病毒已经在 胆道闭锁的病因是围产期病毒感染 引发免疫介导的胆管上皮破坏。胆管炎小鼠模型 新生小鼠感染恒河猴轮状病毒(RRV)后, 门脉道内出现炎症和肝外胆管阻塞。RRV目标 胆管细胞的感染,除了直接的胆管细胞损伤也诱导自然 杀伤细胞介导的胆管上皮损伤。 我们先前已经表明,序列“SRL”(氨基)内的氨基酸精氨酸(R) 氨基酸445-447)是病毒结合和进入胆管上皮细胞所必需的 细胞我们开发了反向遗传学系统来创建RRV的突变体(RRVVP 4-R446 G), 与野生型RRV相比,在VP 4蛋白中具有单个氨基酸变化。在体外,突变体 病毒在胆管细胞中的结合和感染性降低。在体内, 和新生小鼠的死亡率,导致胆道闭锁的减弱形式。我们将使用这个 突变株沿着额外的VP 4突变体,以确定RRV如何结合、进入、运输 并最终激活胆管细胞的先天免疫反应。我们将 还确定了这些VP 4突变体感染和激活浆细胞样树突状细胞的能力, 自然杀伤细胞激活这些互补的方法将产生新的见解, 诱发胆道闭锁。

项目成果

期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Rotavirus replication in the cholangiocyte mediates the temporal dependence of murine biliary atresia.
  • DOI:
    10.1371/journal.pone.0069069
  • 发表时间:
    2013
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Mohanty SK;Donnelly B;Bondoc A;Jafri M;Walther A;Coots A;McNeal M;Witte D;Tiao GM
  • 通讯作者:
    Tiao GM
Role of myeloid differentiation factor 88 in Rhesus rotavirus-induced biliary atresia.
骨髓分化因子 88 在恒河猴轮状病毒诱导的胆道闭锁中的作用。
  • DOI:
    10.1016/j.jss.2013.05.032
  • 发表时间:
    2013
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Walther,AshleyE;Mohanty,SujitK;Donnelly,Bryan;Coots,Abigail;McNeal,Monica;Tiao,GregoryM
  • 通讯作者:
    Tiao,GregoryM
Rotavirus infection of human cholangiocytes parallels the murine model of biliary atresia.
  • DOI:
    10.1016/j.jss.2012.05.082
  • 发表时间:
    2012-10
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Coots A;Donnelly B;Mohanty SK;McNeal M;Sestak K;Tiao G
  • 通讯作者:
    Tiao G
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

GREGORY M TIAO其他文献

GREGORY M TIAO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('GREGORY M TIAO', 18)}}的其他基金

The Molecular Determinants of Virus Induced Biliary Atresia
病毒引起的胆道闭锁的分子决定因素
  • 批准号:
    8085527
  • 财政年份:
    2011
  • 资助金额:
    $ 44.58万
  • 项目类别:
The Molecular Determinants of Virus Induced Biliary Atresia
病毒引起的胆道闭锁的分子决定因素
  • 批准号:
    8449192
  • 财政年份:
    2011
  • 资助金额:
    $ 44.58万
  • 项目类别:
The Molecular Determinants of Virus Induced Biliary Atresia
病毒引起的胆道闭锁的分子决定因素
  • 批准号:
    8243504
  • 财政年份:
    2011
  • 资助金额:
    $ 44.58万
  • 项目类别:
Intracellular signaling pathways and virus induced biliary atresia
细胞内信号通路与病毒诱导的胆道闭锁
  • 批准号:
    7875916
  • 财政年份:
    2010
  • 资助金额:
    $ 44.58万
  • 项目类别:
Intracellular signaling pathways and virus induced biliary atresia
细胞内信号通路与病毒诱导的胆道闭锁
  • 批准号:
    8051858
  • 财政年份:
    2010
  • 资助金额:
    $ 44.58万
  • 项目类别:
Pathogenic Mechanisms of Virus Induced Biliary Atresia
病毒性胆道闭锁的发病机制
  • 批准号:
    7261173
  • 财政年份:
    2005
  • 资助金额:
    $ 44.58万
  • 项目类别:
Pathogenic Mechanisms of Virus Induced Biliary Atresia
病毒性胆道闭锁的发病机制
  • 批准号:
    7121806
  • 财政年份:
    2005
  • 资助金额:
    $ 44.58万
  • 项目类别:
Pathogenic Mechanisms of Virus Induced Biliary Atresia
病毒性胆道闭锁的发病机制
  • 批准号:
    6961713
  • 财政年份:
    2005
  • 资助金额:
    $ 44.58万
  • 项目类别:
Pathogenic Mechanisms of Virus Induced Biliary Atresia
病毒性胆道闭锁的发病机制
  • 批准号:
    7637736
  • 财政年份:
    2005
  • 资助金额:
    $ 44.58万
  • 项目类别:
INTRAVENOUS METHYLPREDNISOLONE VS ORAL PREDNISOLONE IN TRANSPLANT REJECTION
静脉注射甲基泼尼松龙与口服泼尼松龙在移植排斥中的比较
  • 批准号:
    7374506
  • 财政年份:
    2005
  • 资助金额:
    $ 44.58万
  • 项目类别:

相似海外基金

Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
  • 批准号:
    10682121
  • 财政年份:
    2023
  • 资助金额:
    $ 44.58万
  • 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
  • 批准号:
    10576370
  • 财政年份:
    2022
  • 资助金额:
    $ 44.58万
  • 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
  • 批准号:
    10387023
  • 财政年份:
    2022
  • 资助金额:
    $ 44.58万
  • 项目类别:
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
  • 批准号:
    10248409
  • 财政年份:
    2019
  • 资助金额:
    $ 44.58万
  • 项目类别:
A phase I clinical study of adoptive transfer of regulatory T cells (Tregs) and low-dose interleukin-2 (IL-2) for the treatment of chronic graft-versus-host disease (GVHD): gene-marking to inform rational combination therapy
调节性 T 细胞 (Treg) 和低剂量白细胞介素 2 (IL-2) 过继转移治疗慢性移植物抗宿主病 (GVHD) 的 I 期临床研究:基因标记为合理的联合治疗提供信息
  • 批准号:
    nhmrc : GNT1163111
  • 财政年份:
    2019
  • 资助金额:
    $ 44.58万
  • 项目类别:
    Project Grants
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
  • 批准号:
    10462684
  • 财政年份:
    2019
  • 资助金额:
    $ 44.58万
  • 项目类别:
Gene edited lymphoid progenitors for adoptive transfer as a treatment of primary immunodeficiency
基因编辑的淋巴祖细胞用于过继转移作为原发性免疫缺陷的治疗
  • 批准号:
    398018062
  • 财政年份:
    2018
  • 资助金额:
    $ 44.58万
  • 项目类别:
    Research Grants
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
  • 批准号:
    9308643
  • 财政年份:
    2017
  • 资助金额:
    $ 44.58万
  • 项目类别:
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
  • 批准号:
    9447149
  • 财政年份:
    2017
  • 资助金额:
    $ 44.58万
  • 项目类别:
Targeting Cancer miRNAs by Adoptive Transfer of Programmed B Lymphocytes
通过程序化 B 淋巴细胞的过继转移靶向癌症 miRNA
  • 批准号:
    8893915
  • 财政年份:
    2014
  • 资助金额:
    $ 44.58万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了